NTT DATA Launches Global Business Unit for Microsoft Cloud to Accelerate Enterprise Transformation in the AI Era
7.8.2025 14:00:00 CEST | Business Wire | Press Release
NTT DATA, a global leader in digital business and technology services, today announced its NTT Data business unit for Microsoft Cloud to meet rising demand for secure, AI-driven enterprise cloud transformation. The global unit brings together NTT DATA’s deep industry and technical expertise in Microsoft Cloud, security and AI solutions to accelerate cloud modernization, scale Agentic AI and navigate complex sovereignty and compliance requirements.
“Our expanded collaboration with Microsoft reflects a shared commitment to helping clients tackle today’s complex business challenges with speed, scale and trust,” said Charlie Li, Head of Cloud and Security Services, NTT DATA, Inc. “Through our global business unit for Microsoft Cloud, we’re bringing together the strengths of both organizations to solve modern problems using advanced cloud and AI technologies, whether it’s modernizing operations, improving how people work and connect, or delivering more intelligent, secure and resilient digital experiences.”
Global NTT Data business unit for Microsoft Cloud: scale and specialization
With a presence across more than 50 countries and a deep bench of Microsoft certified specialists holding 24,000 certifications, the NTT DATA business unit for Microsoft Cloud helps clients accelerate digital transformation globally. This unit brings together technical expertise in cloud-native development, cybersecurity, observability and Agentic AI, while staying closely aligned with Microsoft’s technology roadmap and engineering teams.
Led by Aishwarya Singh, Senior Vice President and Head of the Global Business Unit for Microsoft Cloud, the unit buildson NTT DATA’s longstanding strategic alliance with Microsoft to elevate existing capabilities and expands its global reach, reinforcing NTT DATA’s role as a trusted enterprise transformation partner.
To accelerate adoption, NTT DATA is aligning its sales, pre-sales and delivery teams with Microsoft to help clients design, build, secure, migrate and implement solutions on Microsoft Cloud that deliver measurable business impact across industries and regulated markets.
Core areas of focus include:
- Agentic AI at scale: Helping clients rapidly scale AI agents with Microsoft 365 Copilot and Microsoft Azure AI Foundry enabling real-time voice communications and intelligent orchestration with speed, efficiency and ethical integrity.
- Modern cloud solutions: Supporting organizations in building and updating applications In Microsoft Azure to boost agility, reduce complexity and stay ahead of change.
- Developer acceleration: Empowering Azure developers to accelerate cloud-native development with a microservices library of 500+ industry-accelerators, built on top of NTT DATA’s Industry Cloud platform.
- Enhanced digital experience: Enabling more connected, collaborative workplaces with Microsoft 365 and transforming customer engagement through integrated Microsoft Dynamics 365 Contact Center solutions.
- Sovereign cloud adoption: NTT DATA is one of the few Microsoft partners collaborating on Sovereign Cloud specialization under Microsoft AI Cloud partner program.
Driving agentic AI adoption at scale
Today’s announcement also follows strong momentum for NTT DATA’s recently launched Agentic AI Services for Hyperscaler AI Technologies, built on Azure and Azure AI Foundry. In just 90 days, these services have generated nearly 100 enterprise client opportunities, including Newell Brands.
This interest underscores the growing demand for AI-powered automation, intelligent workflows and seamless enterprise integration and the need for scalable solutions that move AI out of the lab and into production. NTT DATA is also scaling support for multi-agent models by leveraging Azure AI Agent Service on Azure AI Foundry. As a result, NTT DATA can help clients build, manage and orchestrate multi-agent workflows across multiple platforms.
Providing next-generation service delivery
NTT DATA is uniquely positioned to lead cloud-native business transformation in the AI era with deep expertise across Azure, Agentic AI and Industry Cloud ecosystems. Backed by 27 Advanced Specializations, including Security, Data & AI for Azure, Infrastructure, Digital & App Innovation and AI Business Solutions, NTT DATA helps enterprises accelerate big data migration and analysis, scale AI and ML workloads with flexibility and implement cost-effective, composable infrastructures that drive innovation and resilience.
“NTT DATA has played a pivotal role in driving global adoption of Microsoft Azure innovations. This global business unit and our expanded collaboration enables enterprises to integrate AI seamlessly, modernize operations and achieve digital transformation with confidence," said Stephen Boyle, Global Leader, SI & Advisory at Microsoft.
Learn more about NTT DATA and Microsoft here.
About NTT DATA
NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future.
Visit us at nttdata.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250807490453/en/
Contacts
Lori Bosio
Lori.bosio@nttdata.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom